Navigation Links
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
Date:2/12/2008

SAN CARLOS, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced a restructuring today designed to complete its transition from a drug delivery service provider to a therapeutics drug development organization. The restructuring will streamline the company, consolidate corporate functions, and strengthen decision-making and execution within the business units.

"We are transforming Nektar into a world-class drug development company and these changes are a natural progression on the path to achieving this vision," said Howard W. Robin, President and Chief Executive Officer of Nektar. "This restructuring aligns the organization with the future direction of our company and strengthens our ability to drive programs rapidly through the clinic."

Approximately 150 positions have been eliminated as a result of the restructuring. Importantly, Nektar has preserved the necessary technical and manufacturing personnel and capabilities to support its ongoing effort to forge a new partnership for its inhaled insulin programs.

Nektar has made significant progress this past year in advancing its proprietary pipeline. The company recently initiated phase 2 clinical trials for its two leading PEGylated small molecule programs, NKTR-102 (PEG-irinotecan) for solid tumors and NKTR-118 (oral PEG-naloxol) for opioid bowel dysfunction. NKTR-061 (inhaled amikacin), which is being co-developed with Bayer AG to treat hospital-acquired pneumonia, is expected to enter Phase 3 trials this year.

The company will release its full financial results for the fourth quarter and full year 2007 on February 27, 2008. At that time, it will host a conference call for investors and analysts beginning at 2:00 PM PT/5:00 PM
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
2. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
3. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
4. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
5. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
6. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
7. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. PAREXEL International Announces 2-For-1 Stock Split
10. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
11. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...l. You can think of it as origami very high-tech...nois have developed a technique for fabricating th...ures from thin films by coupling photolithography ...eractions. , The films, only a few microns thick,... with thicker pieces of the same material. , "Thi...
(Date:11/23/2009)...AUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSciences...velopmentcompanythatidentifiesandadvancesadiversep...stagesofdevelopment,todayreportedthatCytopia(ASX:C...ngCYT387,apotent,orally-administeredJAK1/JAK2inhib...er,Minnesota.AproposaltomergeCytopiaintoYMhasbeenp...
(Date:11/23/2009)...,BC,Nov.23/PRNewswire/-InimexPharmaceuticals,Inc.a...DasitsPresidentandCEO. ,, Abramsbringsmorethan2...mex.Heisaco-inventorofthenuclearmedicineimagingage...hey,plcwherehewasManager,BiomedicalResearchWorldwi...ley,BCandwasPresidentandCEOfrom1996to2006.AnorMEDd...
(Date:11/20/2009)... , , , , , , , ... AUDIO: , A team of scientists from Washi...rizona, Cold Spring Harbor Laboratory and Iowa Sta...orn. The... , , Click here for mo... , , , , , , , ...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Inimex Announces Appointment of New CEO 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
... CITY, April 16 ARUP Laboratories, a national,cli...and a leader in,innovative laboratory research and...der Carl R. Kjeldsberg, MD, will retire as chief e...eldsberg has held the position,since 1993 and will...n of,the Board., Effective, July 1, 2009, Edward ...
...Also Celebrates Opening of Hollings Expanded Build...ersity of,South Carolina,s Hollings Cancer Center ...ling Garden. The healing garden, designed by Rober...Edwin S. Pearlstine, Jr., in memory,of his wife of...cancer in,1997., "Edwin and Barbara Pearlstine wi...
...nd CLAREMONT, Calif., Apr 16 /Xinhua-PRNewswire-Fi...on (OTC Bulletin Board: KWBT), ("the,Company" and ...Li, General,Manager of Huaxing Animal Medicine Co....njun Luo, Kiwa CFO, at Kiwa Beijing headquarters. ...isal of the assets, both parties,signed a memorand...
Other Biology Technology:ARUP Laboratories CEO and Co-Founder Announces Retirement 2MUSC's Hollings Cancer Center Dedicates Edwin and Barbara Pearlstine Healing Garden Endowed with $1 Million Gift from Edwin S. Pearlstine, Jr. 2Kiwa and Huaxing Set Up Preparatory Team for New Joint-venture Company 2
(Date:11/22/2009)...scientists have succeeded in producing the polymer...g, rather than through the use of fossil fuel base...ay now allow for the production of environmentally... the journal Biotechnology and Bioengineering to...s are molecules found in everyday life in the form...
(Date:11/22/2009)... can increase the likelihood of immune complicatio...national team of researchers reports in the Novemb...hen the gene, called UGT2B17, is missing from the ...nsplants have a significantly greater risk of a se...se, in which immune cells from the donor attack ti...
(Date:11/22/2009)... Agios Pharmaceuticals today announced that its s...at the mutated IDH1 gene has a novel enzyme activi...ene. This breakthrough discovery shows that the mu...yglutarate (2HG), which may contribute to the form...st common type of brain cancers. This discovery ap...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4Many Young Adults Uninformed About Vaccines 52443 1Many Young Adults Uninformed About Vaccines 52443 2Many Young Adults Uninformed About Vaccines 52443 3SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 1SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 2SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 3SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 4Counterfeit antimalarial drug discovered in Ghana 52436 1Counterfeit antimalarial drug discovered in Ghana 52436 2Counterfeit antimalarial drug discovered in Ghana 52436 3
...scientists replace pricey solvents with cheap proc...rge-scale manufacture of fluorescent quantum dots,...w method of replacing the pricey solvents used in ...ommonplace at industrial chemical plants. , Rice,s...the Center for Biological and Environmental Nanote...
...r computation of haplotypes provides insight into ...encing of an individual,s DNA yields a map of gene...underpinning of human disease. The current techno...individual,s two chromosomes. Yet many scientists...een individuals, DNA at the level of each chromoso...
...h quick to caution about the many things that coul...e to contain a Southeast Asian outbreak of avian i...roduction of a vaccine. , Using a computer model t...population, the scientists have shown how a combin...tion of antivirals, quarantine and prevaccination ...
Other Biology News:Method slashes quantum dot costs by 80 percent 2Method slashes quantum dot costs by 80 percent 3U-M scientists say fused genes trigger the development of prostate cancer 2U-M scientists say fused genes trigger the development of prostate cancer 3U-M scientists say fused genes trigger the development of prostate cancer 4Preventing a pandemic: Study suggests strategies for containing a flu outbreak 2Preventing a pandemic: Study suggests strategies for containing a flu outbreak 3
Custom siRNA, standard purity, annealed from Ambion
...y amplify unknown genomic DNA using our patented ...y-to use components, at an extraordinarily competi... in each kit. The Locator Kit can be used for iden...ional sequence extension of sequence-tagged sites ...
Rabbit Anti-Human YIPF6 Polyclonal Antibody, Unconjugated from Atlas Antibodies
...rform Heat Induced Antigen Retrieval (HIER) on for...ted on glass microscope slides. Deparffinization i... temperature used in HIER (over 90degrees C) along... Formaldehyde fixation impairs or totally destroys...
Biology Products: